Platform
Features
Glyscend Incorporated
Contact
No bio yet
Links
Mark Fineman
Chief Development Officer
Sign up to view 0 direct reports
Get started
4 members
Agenus
Avantor
Destiny Pharma
TenNor Therapeutics
Systems Oncology